Canada Drugs Direct

Visiting from Canada?

Want to save up to 80% on your medications? Signup below to be notified if we open a Canadian Online Pharmacy.

I agree to receive email updates from Canada Drugs Direct

Looking for Call us toll free 1-800-500-2897

Beovu (Brolucizumab)

Prescription medicineOnly Available By Prescription

What if I find a lower price with another pharmacy?

We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!

Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.

To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.

Terms & Conditions of Program

  • Guaranteed lowest price is only valid at the time of sale.
  • We will only match the current advertised price.
  • Products must be identical and in stock at the time of placing an order with a licensed mail order pharmacy. They must be an online Canadian pharmacy with an address in Canada.
  • Products must be authentic in brand and size (same manufacturer, same country of manufacture, same pack size, same strength and same quantity).
  • Products must be new. We cannot match the price of any used, short expiry or expired product.
  • Price match can only be issued over the phone with our customer service team. Please note at this time we cannot offer price matching for the products Ozempic or Saxenda.
What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.


Beovu (Brolucizumab) is an eye injection used to treat neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME). It works by inhibiting vascular endothelial growth factor (VEGF), a protein that promotes abnormal blood vessel formation in the eye. Beovu helps to manage the growth of these vessels, aiming to preserve vision in patients with AMD or DME. Beovu is administered as an injection into the eye by healthcare professionals.


Beovu is injected directly into the eye by a healthcare professional trained in administering intravitreal injections. The typical starting dose is 6 mg (0.05 mL of a 120 mg/mL solution). Patients typically receive this dose once every month for the first three doses for AMD or once every six weeks for the first five doses for DME. Afterward, the dosing frequency may change to once every eight to twelve weeks as directed by a physician. It's important for patients to follow their doctor's specific instructions about follow-up appointments and treatment schedules.


Brolucizumab-dbll is the active ingredient in Beovu.


Avoid taking or using this medication if any of the following apply:

  • Previous Allergic Reactions: Patients with a known allergy to Brolucizumab or any of the components in Beovu
  • Active Infection: Presence of any infection in or around the eyes
  • Active Intraocular Inflammation: Signs of inflammation inside the eye, such as iritis or uveitis


  • Talk to a healthcare provider about any of the following before starting treatment:
    • Any allergies
    • Other medications you’re taking
    • Other medical conditions you have
    • Whether you’re pregnant or breastfeeding
  • Intravitreal injections of Beovu carry a risk of serious eye conditions like endophthalmitis (a severe eye infection) and retinal detachment. You should be aware of symptoms such as eye pain, blurred vision, or seeing flashes of light and report them to your doctor immediately.
  • Following Beovu injections, there have been reports of retinal vasculitis and retinal vascular occlusion, which are conditions related to inflammation and blockage of blood vessels in the eye. It's important to monitor any vision changes and contact your eye specialist promptly if you notice any alterations.
  • After receiving a Beovu injection, the pressure inside your eye (intraocular pressure or IOP) can increase rapidly, sometimes within just 30 minutes. Regular eye pressure checks are important.
  • VEGF inhibitors like Beovu used in the eye have a potential risk associated with arterial thromboembolic events (such as heart attacks or strokes). Be aware of this risk, especially if you have pre-existing heart conditions.

Side Effects

In treating eye conditions, Beovu commonly causes blurred vision, cataracts (cloudy areas in the eye lens), eye bleeding, floaters (tiny spots in your vision), eye pain, increased eye pressure, and eye redness or irritation. Patients might also experience eye dryness, increased tearing, sensations of something in the eye, and vision changes.

More severe issues with Beovu include serious allergic reactions, infections inside the eye, retina detachment (the back layer of the eye pulling away), blood vessel blockages in the retina, and significantly increased eye pressure. Patients should promptly report any sudden vision changes, intense eye pain, or major discomfort to their healthcare provider. Regular eye check-ups are important for those on Beovu treatment.


  1. Beovu (Brolucizumab) Product Monograph. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2023.
  2. Beovu (Brolucizumab) Drug Label Information. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2023.

IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

product reviews icon Product Reviews